首页> 外文期刊>Pharmacological reviews >International Union of Pharmacology. XXXI. Recommendations for the Nomenclature of Multimeric G Protein-Coupled Receptors.
【24h】

International Union of Pharmacology. XXXI. Recommendations for the Nomenclature of Multimeric G Protein-Coupled Receptors.

机译:国际药理学联合会。 XXXI。多聚体G蛋白偶联受体命名法的建议。

获取原文
获取原文并翻译 | 示例
       

摘要

A receptor is defined by the International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) as a protein, or a complex of proteins, which recognizes physiologically relevant ligands that can regulate the protein to mediate cellular events (). This definition does not include associated proteins, which are not required for agonist recognition and/or receptor assembly. Thus, G proteins are not included in the nomenclature of G protein-coupled receptors (GPCRs). Similarly, proteins which modify receptor disposition, such as proteins with a PDZ domain (), and which associate with the cytosolic portion of the receptor are not included. The question arises, however, as to the way to name multimeric receptors where subunits influence receptor assembly and agonist recognition. The essential issue is whether to name the individual proteins or the association of proteins? NC-IUPHAR recommends that, where possible, the functional receptor complex be given a different name from that of the subunits.
机译:受体由国际药理学联合会命名法和药物分类委员会(NC-IUPHAR)定义为一种蛋白质或蛋白质复合物,可识别可调节该蛋白质以介导细胞事件的生理相关配体。该定义不包括激动剂识别和/或受体组装所不需要的相关蛋白质。因此,G蛋白不包括在G蛋白偶联受体(GPCR)的命名法中。类似地,不包括改变受体分布的蛋白质,例如具有PDZ结构域的蛋白质,并且与受体的胞质部分缔合。然而,关于亚基影响受体组装和激动剂识别的多聚体受体的命名方式出现了问题。关键问题是要命名单个蛋白质还是蛋白质的结合? NC-IUPHAR建议在可能的情况下,为功能性受体复合物赋予与亚基不同的名称。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号